KR100721484B1 - 사람의 퓨즈드 억제제와 관련된 핵산, 폴리펩티드 및 항체 - Google Patents

사람의 퓨즈드 억제제와 관련된 핵산, 폴리펩티드 및 항체 Download PDF

Info

Publication number
KR100721484B1
KR100721484B1 KR1020017011256A KR20017011256A KR100721484B1 KR 100721484 B1 KR100721484 B1 KR 100721484B1 KR 1020017011256 A KR1020017011256 A KR 1020017011256A KR 20017011256 A KR20017011256 A KR 20017011256A KR 100721484 B1 KR100721484 B1 KR 100721484B1
Authority
KR
South Korea
Prior art keywords
hsu
cell
sequence
cells
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020017011256A
Other languages
English (en)
Korean (ko)
Other versions
KR20010113036A (ko
Inventor
프레데릭 제이. 드소베지
오스틴 엘. 거니
막시밀리앙 뮤론
아논 로젠탈
도나 엠. 스톤
윌리암 아이. 우드
Original Assignee
제넨테크, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제넨테크, 인크. filed Critical 제넨테크, 인크.
Publication of KR20010113036A publication Critical patent/KR20010113036A/ko
Application granted granted Critical
Publication of KR100721484B1 publication Critical patent/KR100721484B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Glass Compositions (AREA)
KR1020017011256A 1999-03-05 2000-03-02 사람의 퓨즈드 억제제와 관련된 핵산, 폴리펩티드 및 항체 Expired - Lifetime KR100721484B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12309099P 1999-03-05 1999-03-05
US60/123,090 1999-03-05
US13573699P 1999-05-25 1999-05-25
US60/135,736 1999-05-25

Publications (2)

Publication Number Publication Date
KR20010113036A KR20010113036A (ko) 2001-12-24
KR100721484B1 true KR100721484B1 (ko) 2007-05-23

Family

ID=26821226

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017011256A Expired - Lifetime KR100721484B1 (ko) 1999-03-05 2000-03-02 사람의 퓨즈드 억제제와 관련된 핵산, 폴리펩티드 및 항체

Country Status (9)

Country Link
EP (1) EP1159421B8 (https=)
JP (1) JP4659219B2 (https=)
KR (1) KR100721484B1 (https=)
AT (1) ATE447614T1 (https=)
AU (1) AU779258B2 (https=)
CA (1) CA2362963C (https=)
DE (1) DE60043258D1 (https=)
NZ (1) NZ513762A (https=)
WO (1) WO2000052166A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448020B1 (en) * 1997-12-19 2002-09-10 Rune Toftgard Molecules associated with the human suppressor of fused gene

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Genbank Accession No. AA223637 *
Genbank Accession No. AA223637(1998. 3. 12., 이하 인용발명이라 함) *

Also Published As

Publication number Publication date
EP1159421B1 (en) 2009-11-04
DE60043258D1 (de) 2009-12-17
ATE447614T1 (de) 2009-11-15
JP4659219B2 (ja) 2011-03-30
NZ513762A (en) 2001-09-28
CA2362963C (en) 2014-05-06
JP2002537812A (ja) 2002-11-12
CA2362963A1 (en) 2000-09-08
WO2000052166A1 (en) 2000-09-08
AU779258B2 (en) 2005-01-13
AU3867000A (en) 2000-09-21
EP1159421B8 (en) 2010-02-17
EP1159421A1 (en) 2001-12-05
KR20010113036A (ko) 2001-12-24

Similar Documents

Publication Publication Date Title
JP2001517439A (ja) ５３ｂｐ２複合体
US20030064477A1 (en) Novel E6 targeted protein (E6TP1)
US20020048794A1 (en) Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von Hippel-Lindau tumor suppressor protein
AU2001290179A1 (en) Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
KR100721484B1 (ko) 사람의 퓨즈드 억제제와 관련된 핵산, 폴리펩티드 및 항체
US7579161B2 (en) Assay methods for suppressor of fused modulation of hedgehog signaling
EP0935653A1 (en) Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
US6673902B2 (en) Cyclin D binding factor, and uses thereof
US8648174B2 (en) Ucp4
ZA200106937B (en) Human suppressor of fused.
EP1135496B1 (en) Ucp5
US7342102B2 (en) Uncoupling protein 5 (UCP5)
US20020019020A1 (en) Methods for treating cardiovascular disorders
JP2002533062A5 (https=)

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20010904

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20050207

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060421

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20061201

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20060421

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20070305

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20061201

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20070503

Appeal identifier: 2007101002516

Request date: 20070305

AMND Amendment
PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20070329

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20070305

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20070305

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20060721

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20050207

Patent event code: PB09011R02I

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20070503

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20070405

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20070517

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20070518

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
G170 Re-publication after modification of scope of protection [patent]
PG1701 Publication of correction
PR1001 Payment of annual fee

Payment date: 20100512

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20110421

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20120423

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20130429

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20130429

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20140430

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20140430

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20160330

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20160330

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20170330

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20170330

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20180329

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20180329

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20190327

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20190327

Start annual number: 13

End annual number: 13

PC1801 Expiration of term

Termination date: 20200902

Termination category: Expiration of duration